If this approach truly worked, wed see far more research and legitimate medical products using it, but right now, the science doesnt support the claims
CrossRef Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events Daqiu Chen, Zixun Wang, Zhanxiong Xie, Yixing Chen, Shunxiang Luo, Shanghua Xu Frontiers in Pharmacology.2026;[Epub] CrossRef Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study Ying Wang, Hongning Li, Zhongyuan Zhang, Xiaocen Kong, Huiqin Li, Weichun Qian, Jianhua Ma Frontiers in Endocrinology.2026;[Epub] CrossRef Inflammation-autonomic cross talk contributes to left ventricular diastolic dysfunction in type 2 diabetes: a rationale for neuromodulation Nuwani Wijesooriya, Senali Silva, Dulani Kottahachchi, Nadisha Badanasinghe, Dinu S
The BPC-157 research peptide represents a potential regenerative compound, which after research in humans could be relevant to many kinds of injuries, including organ, glut, skin disorders and wounds
Okeke F, Roland BC, Mullin GE
Nov 2008;116(10):600-605